Luis A. Pérez‐de‐Llano

Author

Also Known As

L. A. Perez-de-Llano, L. A. Pérez-de-Llano, L.A. Pérez-de-Llano, LUIS A. PÉREZ‐DE‐LLANO, Luis A Pérez-de-Llano, Luis A. Pérez-de-Llano, Luis A. Pérez‐de‐Llano

Publications

466

Citations

H-Index

Concepts

All Affiliations

Hospital Universitario Lucus Augusti Hospital Xeral Calde Marqués de Valdecilla University Hospital

About

Luis A. Pérez‐de‐Llano is an author at Hospital Universitario Lucus Augusti specializing in medicine, cardiovascular disease, and hypertension.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	122
2	Public Health	3	3	90
3	Emergency Medicine	3	3	79
4	Health Sciences	1	1	14
5	Epidemiology	1	1	25

Luis A. Pérez‐de‐Llano

Publications

367

Citations

H-Index

Page 1

	Year	Citations
Haemodynamic effects of non‐invasive ventilation in patients with obesity‐hypoventilation syndrome Olalla Castro‐Añón, Rafael Golpe, Luis A. Pérez‐de‐Llano, Respirology	2012	78
Exhaled nitric oxide predicts control in patients with difficult-to-treat asthma Luis A. Pérez‐de‐Llano, Francisco Carballada, Olalla Castro‐Añón, European Respiratory Journal	2009	65
Prognostic Value of Walk Distance, Work, Oxygen Saturation, and Dyspnea During 6-Minute Walk Test in COPD Patients Rafael Golpe, Luis A. Pérez‐de‐Llano, Lidia Méndez‐Marote, Respiratory Care	2013	53
Right ventricle dysfunction and pulmonary hypertension in hemodynamically stable pulmonary embolism Rafael Golpe, Luis A. Pérez‐de‐Llano, Olalla Castro‐Añón, Respiratory Medicine Pulmonary EmbolismRight Ventricle DysfunctionHeart FailureStable Pulmonary EmbolismPulmonary Arterial Hypertension	2010	51
Prognostic Indices and Mortality Prediction in COPD Caused by Biomass Smoke Exposure Rafael Golpe, Noemí Mengual-Macenlle, Pilar Sanjuán-López, Lung Biomass Smoke ExposureMortality PredictionGlobal HealthPulmonary DiseasePrognostic Indices	2015	25
Risk of severe COVID-19 in hypertensive patients treated with renin-angiotensin-aldosterone system inhibitors Rafael Golpe, Luis A. Pérez‐de‐Llano, David Dacal, Medicina Clínica HypertensionCardiovascular DiseaseHypertensive PatientsAntihypertensive TherapyCardiovascular Pharmacology	2020	24
Risk of severe COVID-19 in hypertensive patients treated with renin-angiotensin-aldosterone system inhibitors Rafael Golpe, Luis A. Pérez‐de‐Llano, David Dacal, Medicina Clínica (English Edition) HypertensionCardiovascular DiseaseHypertensive PatientsAntihypertensive TherapyCardiovascular Pharmacology	2020	19
Prognostic significance of six-minute walk test in non-group 1 pulmonary hypertension Rafael Golpe, Olalla Castro‐Añón, Luis A. Pérez‐de‐Llano, Heart & Lung HypertensionPulmonary Arterial HypertensionPulmonary CirculationCardiovascular DiseasePulmonary Physiology	2013	14
Long-term clinical outcome of patients with persistent right ventricle dysfunction or pulmonary hypertension after acute pulmonary embolism Rafael Golpe, Ana Testa-Fernández, Luis A. Pérez‐de‐Llano, European Journal of Echocardiography	2011	14
Comparison of tinzaparin and acenocoumarol for the secondary prevention of venous thromboembolism: a multicentre, randomized study Luis A. Pérez‐de‐Llano, Virginia Leiro‐Fernández, Rafael Golpe, Blood Coagulation & Fibrinolysis Total CostPharmacotherapyThrombosisVenous ThrombosisHematology	2010	14

Page 1